Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

UPDATE 2-Australia says COVID-19 vaccinations likely to begin February

Published 07/01/2021, 12:30 pm
Updated 07/01/2021, 02:12 pm
© Reuters.

(Recasts to show Australia accelerates COVID-19 vaccine programme, adds TV to slug)

By Colin Packham and Renju Jose

CANBERRA/SYDNEY, Jan 7 (Reuters) - Australia is on course to begin administering the first COVID-19 vaccines in February, Prime Minister Scott Morrison said on Thursday, as the country moves to accelerate its inoculation programme as two states try to contain outbreaks.

Morrison said Australia's pharmaceutical regulator is expected to approve the use of Pfizer (NYSE:PFE)'s PFE.N COVID-19 vaccine by the end of January, with the first doses issued within weeks.

"We are now in a position where believe we will be able to commence vaccinations in mid-to-late February," Morrison told reporters in Canberra.

Australia earlier this week said it expected to begin COVID-19 vaccinations in March.

Australia has reported a total of just over 28,500 COVID-19 cases and 909 deaths since the pandemic began, with border closures and speedy tracking systems helping keep numbers relatively low. (Graphic: https://tmsnrt.rs/34pvUyi)

Authorities are trying to contain new virus clusters in its largest cities, Sydney and Melbourne.

The most populous state New South Wales, the epicentre of the country's latest outbreak, on Thursday said it recorded zero local COVID-19 infections in the past 24 hours.

Australia has ordered 10 million doses of Pfizer's COVID-19 vaccine. It has also struck a deal with AstraZeneca PLC AZN.L that sees the vaccine produced locally.

Morrison said regulatory approval of the AstraZeneca vaccine is expected in February.

Once both are approved, Morrison said Australia aims to vaccinate 80,000 people each week. This would then be expanded in the following four to six weeks, and by the end of March 4 million people could be vaccinated.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The acceleration in the COVID-19 vaccination programme comes amid heightened concern about the spread of the virus globally.

Australia's national cabinet will meet a month earlier than scheduled on Friday, Morrison said, as authorities seek to stop the spread of a more contagious variant of COVID-19 that emerged in Britain. A handful of international arrivals in Australia have tested positive to the UK-strain.

The cabinet meeting will consider a proposals to strengthen travel rules for its citizens and residents returning from overseas, Morrison wrote in a Facebook (NASDAQ:FB) post late Wednesday.

Australian media reported the government has plans to introduce mandatory COVID-19 testing for all international travelers before they board their flights to the country.

Since March, the country has shut its borders to all non-citizens and permanent residents.

($1 = 1.2807 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.